
Wizopan IV Injection
Marketer
Gettin Lifesciences Pvt. Ltd.
Salt Composition
Pantoprazole (40mg)
Overview Wizopan IV Injection
Gastric acid production is suppressed by the intravenous medication, Acidulin IV. Indicated for stomach and intestinal disorders like gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and fosters healing. Acidulin IV also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. A proton pump inhibitor (PPI), it's intravenously administered by medical professionals only when deemed superior to oral formulations. Dosage is individualized, determined by your condition and response. Continue the prescribed treatment duration, even with rapid symptom resolution. Lifestyle modifications, including frequent smaller meals and avoidance of caffeine, spices, and fatty foods, enhance efficacy. Common, generally mild, side effects encompass nausea, vomiting, headache, vertigo, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects necessitate medical consultation. Prolonged use, particularly exceeding one year or at higher doses, may elevate bone fracture risk. Discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your physician. Acidulin IV is contraindicated in patients with severe hepatic impairment, those on HIV medications, individuals with prior PPI allergies, or pre-existing osteoporosis. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or somnolence occurs.
Primary Ingredients of Wizopan IV Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Wizopan IV Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Wizopan IV Injection:
Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.
Common Side effects of Wizopan IV Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Wizopan IV Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Wizopan IV Injection works:
Gastric acid production is suppressed by the intravenous administration of Wizopan, a proton pump inhibitor, thus alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Wizopan IV Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Wizopan IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Wizopan IV Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Wizopan IV Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Intravenous Wizopan administration is considered safe for individuals with renal impairment. No modification of the Wizopan IV Injection dosage is necessary.
LiverCAUTION
Intravenous Wizopan administration requires careful monitoring in individuals with advanced hepatic impairment. Dosage modification for Wizopan IV Injection may be necessary. Physician consultation is advised.
What if you forget to take Wizopan IV Injection :
Omit a Wizopan IV Injection dose? Seek your physician's guidance.
Facts to Know About Wizopan IV Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal System |
| Action Class | Gastric acid suppressants |
